Sep 12, 2012 | Allgemein, company news @en, DE
The CEO of Dortmund-based sickness fund BIG, Frank Neumann (48), is on leave of absence with immediate effect. This was confirmed on enquiry by his deputy, Peter Kaetsch, who will take over leadership from Neuman immediately. The reason for the leave of absence was...
Sep 11, 2012 | Allgemein, company news @en, DE
Swiss biotechnology company Actelion has, in the wake of its savings programme, dismissed fewer people from its headquarters than was initially expected. Instead of the initial 70 redundancies planned by the company from Allschwil, Basel, there are now only 40 taking...
Sep 11, 2012 | Allgemein, company news @en, DE
On the 1st August 2012, the revised hospital financial regulations came into effect, with the result being the award of EUR 300 million to hospitals. In determining this amount, it must be equivalent to one third of the total staff remuneration increases above basic...
Sep 11, 2012 | Allgemein, company news @en, DE, general conditions, health policy, market knowledge
Since 2009, antitrust and abusive practice laws have applied for the relationship between statutory sickness funds and service providers (Section 69 Paragraph 2 SGB V). At this point, the legislation took into account the specific conditions of the health care...
Sep 11, 2012 | Allgemein, company news @en, DE
The Gemeinsame Bundesauschuss (G-BA), as part of the discussions about the early benefit assessment, has claimed that proceedings are „clearly positive in this area“ in their initial assessment. (Quote translated by KonMedia) On the side of the...
Sep 11, 2012 | Allgemein, company news @en, DE, transactions
MedImmune, an American biotechnology company arm of AstraZeneca since 2007, and WuXi AppTec, a leading research and development outsourcing comapny have established a joint venture in the Chinese market. The aim of the joint venture is the development and marketing of...
